blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3735996

EP3735996 - BI-DIRECTIONAL PERFUSION CANNULA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.08.2024
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  25.08.2023
FormerGrant of patent is intended
Status updated on  03.05.2023
FormerExamination is in progress
Status updated on  11.06.2021
FormerRequest for examination was made
Status updated on  14.05.2021
FormerThe application has been published
Status updated on  09.10.2020
Most recent event   Tooltip02.08.2024No opposition filed within time limitpublished on 04.09.2024  [2024/36]
Applicant(s)For all designated states
Free Life Medical GmbH
Kleinheidstrasse 1A
52080 Aachen / DE
[2020/46]
Inventor(s)01 / Hildinger, Karl-Heinz
Kleinheidstrasse 1
52080 Aachen / DE
02 / Schmitz, Bernhard
Urftseestrasse 87
53937 Schleiden / DE
03 / Autschbach, Rüdiger
Im Weingarten 2
52074 Aachen / DE
 [2020/46]
Representative(s)Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte
Brucknerstraße 20
40593 Düsseldorf / DE
[2023/39]
Former [2020/46]Gille Hrabal
Brucknerstrasse 20
40593 Düsseldorf / DE
Application number, filing date19172988.807.05.2019
[2020/46]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP3735996
Date:11.11.2020
Language:DE
[2020/46]
Type: B1 Patent specification 
No.:EP3735996
Date:27.09.2023
Language:DE
[2023/39]
Search report(s)(Supplementary) European search report - dispatched on:EP13.11.2019
ClassificationIPC:A61M60/00, A61M1/36, A61M25/00
[2023/18]
CPC:
A61M1/3659 (EP); A61M60/295 (EP,US); A61M1/3666 (EP);
A61M25/00 (EP); A61M60/13 (EP,US); A61M60/38 (EP,US);
A61M60/857 (EP,US); A61M2025/0003 (EP); A61M2025/0073 (EP);
A61M2206/14 (EP); A61M25/005 (EP); A61M25/007 (EP);
A61M25/10 (EP) (-)
Former IPC [2020/46]A61M1/36, A61M25/00, A61M1/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/24]  
Former [2020/46]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:BIDIREKTIONALE PERFUSIONSKANÜLE[2020/46]
English:BI-DIRECTIONAL PERFUSION CANNULA[2020/46]
French:CANULE DE PERFUSION BIDIRECTIONNELLE[2020/46]
Examination procedure06.05.2021Amendment by applicant (claims and/or description)
06.05.2021Examination requested  [2021/24]
06.05.2021Date on which the examining division has become responsible
10.06.2021Despatch of a communication from the examining division (Time limit: M04)
20.07.2021Reply to a communication from the examining division
04.05.2023Communication of intention to grant the patent
22.08.2023Fee for grant paid
22.08.2023Fee for publishing/printing paid
22.08.2023Receipt of the translation of the claim(s)
Opposition(s)28.06.2024No opposition filed within time limit [2024/36]
Fees paidRenewal fee
26.05.2021Renewal fee patent year 03
27.05.2022Renewal fee patent year 04
24.05.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ27.09.2023
ES27.09.2023
HR27.09.2023
PL27.09.2023
RO27.09.2023
RS27.09.2023
SK27.09.2023
SM27.09.2023
NO27.12.2023
GR28.12.2023
IS27.01.2024
[2024/25]
Former [2024/23]CZ27.09.2023
ES27.09.2023
HR27.09.2023
RO27.09.2023
RS27.09.2023
SK27.09.2023
SM27.09.2023
NO27.12.2023
GR28.12.2023
IS27.01.2024
Former [2024/20]HR27.09.2023
RS27.09.2023
SM27.09.2023
NO27.12.2023
GR28.12.2023
IS27.01.2024
Former [2024/11]HR27.09.2023
RS27.09.2023
NO27.12.2023
GR28.12.2023
Former [2024/08]NO27.12.2023
GR28.12.2023
Documents cited:Search[XI]US2005085769  (MACMAHON JOHN M [US], et al);
 [AD]US2018043085  (CHO YANG HYUN [KR]);
 [AD]WO2019075020  (UNIV MARYLAND [US], et al)
by applicantEP0619745
 EP2694148
 US2018043085
 WO2019075020
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.